Europe Smart Pills Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), Disease Indication (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Disease Indications), and End User (Hospitals and Clinics, Research Institutes, and Home Healthcare)

The Europe smart pills market is expected to reach US$ 2,054.19 million by 2028 from US$ 934.08 million in 2021. The market is estimated to grow at a CAGR of 11.9% from 2021 to 2028.

Strategic collaborations are vital for the overall growth of the smart pills market, as these collaborations help increase the influence of the players in the market. The players are involved in mergers, acquisitions, joint ventures, and partnerships. Furthermore, the investment levels in the smart pills market are rapidly growing. The rising popularity of smart pills among the populace attracts several investors. Various companies and investment firms are investing heavily in mergers, acquisitions, and startups. These factors can help boost the growth of the smart pills market. Collaborations agreements between research institutions & companies, licensing agreements & partnerships among companies, and augmented R&D investment in smart pills are a few other factors boosting the market growth. For instance, in January 2021, etectRx, Inc. entered into a partnership agreement with Pear Therapeutics, Inc. to develop two product candidates in the CNS space integrating adherence sensors and prescription digital therapeutics (PDTs). This is the first of its kind partnership in exploring the usage of digital pill solutions with PDTs. In August 2020, Otsuka acquired Proteus Digital Health, the smart pill manufacturer, for US$ 15 million.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the smart pills market. The Europe smart pills market is expected to grow at a good CAGR during the forecast period.

Europe Smart Pills Market Revenue and Forecast to 2028 (US$ Million)

Europe Smart Pills Market Segmentation    

The Europe smart pills market is segmented based on application, disease indication, and end user.Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the Europe smart pills market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.

Europe Smart Pills Market – Companies Mentioned

Medtronic; PENTAX Medical; Olympus Corporation; BodyCap; and Otsuka Holdings Co., Ltd are among the leading companies in the Europe smart pills market.

1.Medtronic
2.PENTAX Medical
3.Olympus Corporation 
4.BodyCap 
5.Otsuka Holdings Co., Ltd.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Smart Pills Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in Europe Smart Pills Market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.